Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Review fee comparisons across wide market index funds to find the lowest-cost option for retirement. Practical guidance to reduce recurring expenses.
28,610 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A renewable-powered data-center company, Iren, surged after unveiling a multi-year Nvidia partnership and ambitious A...
New York billionaire Bill Ackman launches a $260 million brain research center on the Upper West Side after a family ...
XRP-linked ETFs are drawing persistent institutional inflows even as XRP trades in a tight $1.40-$1.47 range. A fresh...
As shipping cycles turn, Safe Bulkers faces a critical earnings season. This guide deconstructs the Q4 2025 call, hig...
SpaceX faces another setback as a Starship test ends without a successful launch. This article breaks down the implic...
Amazon's latest move highlights a broader theme: AI investment can lift near-term costs even as revenue opportunities...
Bitcoin slid below the $73,000 level as Stellar posted a near-19% gain, highlighting a split in crypto markets amid m...
Broadcom's AI outlook miss triggered a pronounced one-day pullback, signaling investor caution around AI-driven growt...
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...
As June trading unfolds, Netflix nudges higher on pricing expectations ahead of its July earnings. The broader market...